BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8578508)

  • 21. Determination of the dosage of recombinant hirudin to inhibit arterial thrombosis in baboons.
    Kotzé HF; Lamprecht S; Van Wyk V; Roodt JP; Badenhorst PN
    J Pharm Sci; 2000 May; 89(5):579-85. PubMed ID: 10756323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Direct thrombin inhibitors].
    Bornkessel B
    Med Monatsschr Pharm; 1997 Apr; 20(4):86-9. PubMed ID: 9198724
    [No Abstract]   [Full Text] [Related]  

  • 23. Leeches to hirulogs and other thrombin-directed antithrombotics.
    Fenton JW
    Hematol Oncol Clin North Am; 1992 Oct; 6(5):1121-9. PubMed ID: 1400076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombin inhibitors and anti-coagulants on thrombin-induced embolisation in rabbit cranial vasculature.
    Liu JT; Paul W; Emerson M; Cicala C; Page CP
    Eur J Pharmacol; 1994 Oct; 264(2):183-90. PubMed ID: 7851481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-induced immune thrombocytopenia.
    Naina HV; Harris S
    N Engl J Med; 2007 Nov; 357(18):1869-70; author reply 1871. PubMed ID: 17978299
    [No Abstract]   [Full Text] [Related]  

  • 26. [New antithrombotic drugs].
    Taliani MR; Agnelli G
    Recenti Prog Med; 1999 Feb; 90(2):86-93. PubMed ID: 10208099
    [No Abstract]   [Full Text] [Related]  

  • 27. Hirudin and thrombosis prophylaxis.
    Turpie AG
    Lancet; 1996 Mar; 347(9002):632-3. PubMed ID: 8596373
    [No Abstract]   [Full Text] [Related]  

  • 28. [Unstable angina pectoris: coagulation disorder and its therapy].
    Meyer BJ
    Praxis (Bern 1994); 1995 Feb; 84(8):232-8. PubMed ID: 7886362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of thrombin inhibitors and a glycoprotein IIb/IIIa receptor antagonist in an ex vivo human experimental thrombosis model.
    Zokai K; Piazolo L; Harenberg J
    Semin Thromb Hemost; 2001 Oct; 27(5):531-6. PubMed ID: 11668424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulating platelet function with selective thrombin inhibitors.
    Verstraete M
    Haemostasis; 1996 Oct; 26 Suppl 4():70-7. PubMed ID: 8979113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The antithrombotic effect of a novel hirudin derivative after reconstruction of carotid artery in rabbits.
    Lu WF; Mo W; Liu Z; Fu WG; Guo DQ; Wang YQ; Song HY
    Thromb Res; 2010 Oct; 126(4):e339-43. PubMed ID: 20483158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serious bleeding in a haemodialysis patient treated with recombinant hirudin.
    Müller A; Huhle G; Nowack R; Birck R; Heene DL; van der Woude FJ
    Nephrol Dial Transplant; 1999 Oct; 14(10):2482-3. PubMed ID: 10528679
    [No Abstract]   [Full Text] [Related]  

  • 33. The future of an illusion.
    Bittl JA
    J Am Coll Cardiol; 2006 Jun; 47(12):2380-3. PubMed ID: 16781362
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of sustained antithrombotic effects of inhibitors of thrombin and factor Xa in experimental thrombosis.
    Biemond BJ; Friederich PW; Levi M; Vlasuk GP; Büller HR; ten Cate JW
    Circulation; 1996 Jan; 93(1):153-60. PubMed ID: 8616922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific thrombin inhibitors ... only one tool of the antithrombotic armamentarium.
    Van De Werf F
    Eur Heart J; 1999 Apr; 20(7):479-80. PubMed ID: 10365282
    [No Abstract]   [Full Text] [Related]  

  • 36. Bivalirudin, thrombin and platelets: clinical implications and future directions.
    Becker R; Butenas S; Carr M; Jaffer F; Kleiman NS; Marmur JD; Schneider DJ; Spiess BD; Steinhubl SR; Weitz JI
    J Invasive Cardiol; 2003 Aug; Suppl():2-15. PubMed ID: 23570139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithrombotic potency of hirudin is increased in nonhuman primates by fibrin targeting.
    Bode C; Hanson SR; Schmedtje JF; Haber E; Mehwald P; Kelly AB; Harker LA; Runge MS
    Circulation; 1997 Feb; 95(4):800-4. PubMed ID: 9054733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycoprotein IIb-IIIa inhibitors - do we still need them?
    Subban V; Sarat Chandra K
    Indian Heart J; 2013; 65(3):260-3. PubMed ID: 23809378
    [No Abstract]   [Full Text] [Related]  

  • 39. Direct thrombin inhibition superior to heparin during and after thrombolysis: dose, duration, and drug.
    Chesebro JH
    Circulation; 1997 Oct; 96(7):2118-20. PubMed ID: 9337177
    [No Abstract]   [Full Text] [Related]  

  • 40. Hirulog: a direct thrombin inhibitor for management of acute coronary syndromes.
    Maraganore JM; Adelman BA
    Coron Artery Dis; 1996 Jun; 7(6):438-48. PubMed ID: 8889359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.